» Articles » PMID: 18373722

Family-based Association Study of Polymorphisms in the RUNX2 Locus with Hand Bone Length and Hand BMD

Overview
Journal Ann Hum Genet
Date 2008 Apr 1
PMID 18373722
Citations 12
Authors
Affiliations
Soon will be listed here.
Abstract

Osteoporosis is characterized by reduced bone strength. Bone size and bone mineral density (BMD) are major bone strength determinants. Identification of genes affecting the variability of these traits should improve prognosis and management of osteoporosis. This research was aimed to test the hypothesis of association of radiographic hand bone length (BL) and BMD with polymorphisms in the RUNX2 locus. Four SNPs linked to the two RUNX2 promoters were genotyped in 212 nuclear Caucasian families. These SNPs and four pairwise haplotypes were tested for association with eight BL and BMD traits, adjusted for covariates. We observed significant associations between polymorphisms linked to the RUNX2 P1 promoter and BL mean values for three studied bone groups: all 18 bones, proximal and medial bones (p = 0.0118, 0.0085, and 0.0056, respectively). Mean BMD values for all 18 bones, proximal and medial bones were associated with polymorphisms linked to the RUNX2 P2 promoter (p = 0.0032, 0.0077, 0.0007, respectively). Associations with BL and BMD mean values for medial and proximal bones remained significant even after correction for multiple testing. This study provides evidence of the association between polymorphisms linked to the two RUNX2 promoters and variability of hand BL and BMD. The results suggest independent roles for the two RUNX2 promoters in the determination of the traits studied.

Citing Articles

Polymorphisms in the Runx2 and osteocalcin genes affect BMD in postmenopausal women: a systematic review and meta-analysis.

Sanyal S, Rajput S, Sadhukhan S, Rajender S, Mithal A, Chattopadhyay N Endocrine. 2023; 84(1):63-75.

PMID: 38055125 DOI: 10.1007/s12020-023-03621-2.


Gene promoter polymorphism of RUNX2 and risk of osteoporosis in postmenopausal Indonesian women.

Auerkari E, Suryandari D, Umami S, Kusdhany L, Siregar T, Rahardjo T SAGE Open Med. 2016; 2:2050312114531571.

PMID: 26770724 PMC: 4607188. DOI: 10.1177/2050312114531571.


Polyalanine repeat polymorphism in RUNX2 is associated with site-specific fracture in post-menopausal females.

Morrison N, Stephens A, Osato M, Pasco J, Fozzard N, Stein G PLoS One. 2013; 8(9):e72740.

PMID: 24086263 PMC: 3781152. DOI: 10.1371/journal.pone.0072740.


Insights from human genetic studies into the pathways involved in osteoarthritis.

Reynard L, Loughlin J Nat Rev Rheumatol. 2013; 9(10):573-83.

PMID: 23958796 DOI: 10.1038/nrrheum.2013.121.


Glutamine repeat variants in human RUNX2 associated with decreased femoral neck BMD, broadband ultrasound attenuation and target gene transactivation.

Morrison N, Stephens A, Osato M, Polly P, Tan T, Yamashita N PLoS One. 2012; 7(8):e42617.

PMID: 22912713 PMC: 3418257. DOI: 10.1371/journal.pone.0042617.